The revenue number was good; especially the contribution from Batesville. The flu season only got worse in January and was joined recently by an additional vomit related bug. However, I think those factors are already reflected in the share price.
The conference call tomorrow will reveal the backlog in orders for the combined company. It is a toss up as to whether it will be adjusted from the conservative preannouncement made in December, after the Coperion aquistion closed. We will know more in a few hours.
HI needs to demonstrate that it can grow in order to justify the share price appreciation during the past few months and that it will indeed handle the increased debt that it is carrying. The EPS number in the current report takes away from that expectation even though it was obvious that they had merger related expenses. It will make the 2014 Q1 report an easy comparison though.